Pfizer CEO Guidelines Out Vaccine Announcement Earlier than Election Day


Editor’s observe: Discover the newest COVID-19 information and steering in Medscape’s Coronavirus Resource Center.

Pharmaceutical firm Pfizer hopes to have security information on a possible coronavirus vaccine by the third week in November, eliminating the likelihood the corporate may apply for emergency use authorization (EUA) earlier than the Nov. 3 election, CEO Albert Bourla mentioned Tuesday on Twitter.

Bourla emphasised the security processes required to place any kind of vaccine in the marketplace.

“We count on to have our security information within the third week of November and the manufacturing course of information earlier than that date. Assuming optimistic information we’ll apply for EUA (emergency use authorization) within the U.S. quickly after the security milestone is achieved,” he mentioned.

Bourla had earlier held out the opportunity of faster outcomes, saying on the Today show that “we could have a solution by the top of October.”

That assertion had boosted the hopes of President Trump, who predicted a vaccine can be out there earlier than Election Day.

In a Sept. 7 news briefing, Trump mentioned: “So we’ll have a vaccine very quickly, possibly even earlier than a really particular date. what date I am speaking about.”

Bourla’s tweets echoed key factors he made in a Tuesday name with buyers and in an open letter posted Oct. 16 on the Pfizer web site.

Within the letter, Bourla mentioned the vaccine have to be confirmed efficient and secure, and it should have the ability to be constantly manufactured.

“Within the occasion of Emergency Use Authorization within the U.S. for a possible COVID-19 vaccine, FDA is requiring that corporations present two months of security information on half of the trial individuals following the ultimate dose of the vaccine,” the letter mentioned. “Based mostly on our present trial enrollment and dosing tempo, we estimate we’ll attain this milestone within the third week of November. …

“All the information contained in our U.S. utility can be reviewed not solely by the FDA’s personal scientists but additionally by an exterior panel of unbiased consultants at a publicly held assembly convened by the company.”

Pfizer is certainly one of 4 corporations conducting third stage medical trials on a coronavirus vaccine, together with Moderna, AstraZeneca and Johnson & Johnson. Pfizer has had essentially the most optimistic timeline.



Right this moment. “Pfizer CEO on coronavirus vaccine: ‘We could have a solution by the top of October”


The White Home. “Remarks by President Trump in Press Convention | September 7, 2020”